Skip Navigation LinksHome > Current Issue > Contributor Index

November 2016 - Volume 31 - Issue 6 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 1 Next
Author Name Article
Alphs, Larry

Benefit–risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Altamura, Alfredo Carlo

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Anta, Lourdes

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Arici, Chiara

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ayani, Ignacio

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Baer, Lee

Ziprasidone augmentation for anxious depression

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bahk, Won-Myong

The role of melatonin and melatonin agonists in counteracting antipsychotic-induced metabolic side effects: a systematic review

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Baker, Ross A.

The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Baldwin, David S.

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Benatti, Beatrice

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Camuri, Giulia

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Carpiniello, Bernardo

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Carrà, Giuseppe

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Castellano, Filippo

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Changzheng

Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder

Open Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
Clerici, Massimo

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cremaschi, Laura

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dell’Osso, Bernardo

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dobrea, Cristina

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fang, Hui

Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fava, Maurizio

Ziprasidone augmentation for anxious depression

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fu, Dong-Jing

Benefit–risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Gommoll, Carl

Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder

Open Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
Gopal, Srihari

Benefit–risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Gutierro, Ibón

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ionescu, Dawn F.

Ziprasidone augmentation for anxious depression

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ivanov, Mikhail

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kramer, Kenneth

Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder

Open Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
Levitan, Bennett

Benefit–risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Liu, Xing Yu

Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Llaudó, Jordi

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Malla, Ashok

The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Markowitz, Michael

Benefit–risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Martínez, Javier

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Meade, Kathryn H.

Ziprasidone augmentation for anxious depression

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Morozova, Margarita

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Nagamizu, Kazuhiro

The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Oldani, Lucio

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ota, Ai

The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Palazzo, Carlotta

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Papakostas, George I.

Ziprasidone augmentation for anxious depression

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Perry, Pamela

The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Primavera, Diego

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Sambunaris, Angelo

Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder

Open Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
Schronen, Juan

Phase I, open-label, randomized, parallel study to evaluate the pharmacokinetics, safety, and tolerability of one intramuscular injection of risperidone ISM at different dose...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Sembira, Ester

Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Shelton, Richard C.

Ziprasidone augmentation for anxious depression

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Soares, Jair C.

Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Swee, Michaela B.

Ziprasidone augmentation for anxious depression

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Thase, Michael E.

Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder

Open Access
Supplemental Author Material
Abstract
PDF
+ Favorites
Request Permissions
Turkoz, Ibrahim

Benefit–risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Wang, Hee Ryung

The role of melatonin and melatonin agonists in counteracting antipsychotic-induced metabolic side effects: a systematic review

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Weiller, Emmanuelle

The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Woo, Young Sup

The role of melatonin and melatonin agonists in counteracting antipsychotic-induced metabolic side effects: a systematic review

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Xu, Gang

Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Zhang, Xiang Yang

Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Zhao, Jingping

Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Zhen, Yan Feng

Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 1 Next